Abeona Therapeutics vs Capricor Therapeutics
Abeona Therapeutics and Capricor Therapeutics are similar in size: $5.8m and $0 of revenue in their latest fiscal years. Abeona Therapeutics grew faster (66.3% against -100.0%). Capricor Therapeutics carries less debt relative to equity (0.0% against 12.6%).
| Latest fiscal year | Abeona TherapeuticsABEO, 2025 | Capricor TherapeuticsCAPR, 2025 |
|---|---|---|
| Revenue | $5.8m | $0 |
| Revenue growth | 66.3% | -100.0% |
| Net income | $71.2m | −$105m |
| Operating margin | -1536.9% | — |
| Net margin | 1223.1% | — |
| Return on equity | 81.8% | -46.6% |
| Free cash flow | −$84.3m | −$72.7m |
| Cash | $78.4m | $288m |
| Total debt | $20.0m | $0 |
| Debt to equity | 12.6% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 226 | 231 |
| Market value | $242m | $478m |
| Price vs our value range | — | — |
| Moat score | 9 (Weak) | 8 (Weak) |
| Insider trades, 12 months | 0 buys, 38 sales | 0 buys, 13 sales |